Evidence map›Paper›PMID 42041570›Full record

ArticleCells2026

Elif Karakoç, Sezai Berkand Koçak, Kevser Kişifli Köş, Hülya Kayhan, Eda Erdem Şahinkesen, Cemil Can Eylem, Ferda Topal Çelikkan, Emirhan Nemutlu, Pergin Atilla

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elif KarakoçDepartment of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.ORCID 0000-0002-0677-1047
Sezai Berkand KoçakDepartment of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.ORCID 0009-0004-0851-1515
Kevser Kişifli KöşArt De Huile, Teknopol İstanbul, İstanbul 34930, Turkey.
Hülya KayhanArt De Huile, Teknopol İstanbul, İstanbul 34930, Turkey.
Eda Erdem ŞahinkesenDepartment of Vaccine Technology, Vaccine Institute, Hacettepe University, Ankara 06230, Turkey.ORCID 0000-0002-8116-0721
Cemil Can EylemDepartment of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara 06230, Turkey.ORCID 0000-0002-3353-2869
Ferda Topal ÇelikkanDepartment of Histology and Embryology, Faculty of Medicine, Ankara University, Ankara 06230, Turkey.ORCID 0000-0002-8254-0558
Emirhan NemutluDepartment of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara 06230, Turkey.ORCID 0000-0002-7337-6215
Pergin AtillaDepartment of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.

Funding

Hacettepe University Research Projects Coordination Unit (BAP) project number TOA-2025-21846
6 · The paper itself

Abstract

Endometriosis is characterized by enhanced cellular proliferation, migration, and resistance to apoptosis, contributing to lesion persistence and progression. Targeting cellular plasticity and mesenchymal-associated functions may therefore represent a promising therapeutic strategy. Here, we investigated the effects of

Indexed as

Cell MovementEndometriosisEndometriumOils, VolatilePelargoniumApoptosisCell LineCell ProliferationEndoplasmic Reticulum Chaperone BiPFemaleHumansEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanOils, Volatileapoptosiselectron microscopyendometriosismesenchymalmetabolomicsmigrationorganellePelargonium graveolensproliferationxCELLigence

Identifiers

PMID42041570
PMCPMC13114720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.